- Previous Close
0.0330 - Open
0.0388 - Bid 0.0320 x --
- Ask 0.0388 x --
- Day's Range
0.0388 - 0.0388 - 52 Week Range
0.0129 - 0.2539 - Volume
6,000 - Avg. Volume
39,693 - Market Cap (intraday)
3.93M - Beta (5Y Monthly) -2.34
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Apr 28, 2025 - May 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
avricore.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AVCRF
View MorePerformance Overview: AVCRF
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVCRF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVCRF
View MoreValuation Measures
Market Cap
3.52M
Enterprise Value
3.35M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.22
Price/Book (mrq)
2.26
Enterprise Value/Revenue
1.02
Enterprise Value/EBITDA
8.42
Financial Highlights
Profitability and Income Statement
Profit Margin
2.18%
Return on Assets (ttm)
3.90%
Return on Equity (ttm)
4.80%
Revenue (ttm)
4.72M
Net Income Avi to Common (ttm)
103.13k
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
790.51k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
365.52k